Nurse Lyndsey, a registered nurse and vaccine injury whistleblower, shares a graphic highlighting a $2 billion lawsuit against Ozempic's manufacturer Novo Nordisk, citing severe side effects like blindness and gastroparesis to urge avoidance of the drug.
Over 1,800 lawsuits allege inadequate warnings for risks including NAION-related vision loss and intestinal blockages, with peer-reviewed studies confirming elevated odds of gastrointestinal events like bowel obstruction (OR 4.22) and pancreatitis in GLP-1 users.
While Ozempic aids substantial weight loss (up to 15% body weight in trials) and may reduce dementia risk, a 2025 Washington University analysis links it to higher kidney and pancreatic issues, emphasizing personalized medical consultation over social media alarms.